Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Flory

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cancers|July 24, 2021
Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate CancerFuqiang Ban, Eric Leblanc, Ayse Derya Cavga, et al.
Journal of Medicinal Chemistry|October 18, 2021
Development of 2-(5,6,7-Trifluoro-1<i>H</i>-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate CancerEric Leblanc, Fuqiang Ban, Ayse Derya Cavga, et al.
Molecular Pharmaceutics|September 23, 2015
Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCsChristopher R Behrens, Edward H Ha, Lawrence L Chinn, et al.
International Journal of Molecular Sciences|August 10, 2024
A Scaled Proteomic Discovery Study for Prostate Cancer Diagnostic Markers Using Proteograph<sup>TM</sup> and Trapped Ion Mobility Mass SpectrometryMatthew E K Chang, Jane Lange, Jessie May Cartier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2022
Engineered nanoparticles enable deep proteomics studies at scale by leveraging tunable nano-bio interactionsShadi Ferdosi, Behzad Tangeysh, Tristan R Brown, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cancers|July 24, 2021
Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate CancerFuqiang Ban, Eric Leblanc, Ayse Derya Cavga, et al.
Journal of Medicinal Chemistry|October 18, 2021
Development of 2-(5,6,7-Trifluoro-1<i>H</i>-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate CancerEric Leblanc, Fuqiang Ban, Ayse Derya Cavga, et al.
Molecular Pharmaceutics|September 23, 2015
Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCsChristopher R Behrens, Edward H Ha, Lawrence L Chinn, et al.
International Journal of Molecular Sciences|August 10, 2024
A Scaled Proteomic Discovery Study for Prostate Cancer Diagnostic Markers Using Proteograph<sup>TM</sup> and Trapped Ion Mobility Mass SpectrometryMatthew E K Chang, Jane Lange, Jessie May Cartier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2022
Engineered nanoparticles enable deep proteomics studies at scale by leveraging tunable nano-bio interactionsShadi Ferdosi, Behzad Tangeysh, Tristan R Brown, et al.
Pageof 3